GenomOncology announced that the GenomOncology (GO) Pathology Workbench has been selected by Personalis to support its NeXT Personal assay for molecular residual disease (MRD)...
Nilogen Oncosystems, a leading Oncology drug development Company; and Scailyte, a single cell AI biomarker discovery company, announced today a strategic partnership to increase...
Athos Therapeutics, Inc. ("Athos"), a late-stage preclinical biotech company using artificial intelligence to develop small molecule therapeutics for immune-mediated diseases and cancer, announced a...
Stealth BioTherapeutics Corp, a clinical-stage biotechnology company focused on the discovery, development, and commercialization of novel therapies for diseases involving mitochondrial dysfunction, announced that...
iNtRON Biotechnology announced that CDL200, a novel biological drug candidate under the development of the world's first enteric colon-targeted capsule formulation for the treatment...
